Cytarabine - Drug Shortage Information

Public shortage context is available across 5 visible NDC detail pages for this generic drug family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

NDC detail pages in this shortage family

Use the NDC detail page when your team needs package-level product details, public shortage references, and a supporting route into quote review workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
Cytarabine 100 mg / mL Injection 20 mL
NDC 63323-0120-20 | 1 Vial, Single-Dose | Fresenius Kabi USA, LLC
63323-0120-20Fresenius Kabi USA, LLCHistorical shortage context
Cytarabine 20 mg / mL Injection 50 mL
NDC 61703-0303-46 | 1 Vial, Pharmacy Bulk Package | Hospira, Inc.
61703-0303-46Hospira, Inc.Historical shortage context
Cytarabine 20 mg / mL Injection 25 mL
NDC 61703-0304-36 | 1 Vial, Multi-Dose | Hospira, Inc.
61703-0304-36Hospira, Inc.Historical shortage context
Cytarabine 20 mg / mL Injection 5 mL
NDC 61703-0305-38 | 5 Vial, Single-Dose | Hospira, Inc.
61703-0305-38Hospira, Inc.Historical shortage context
Cytarabine 100 mg / mL Injection 20 mL
NDC 61703-0319-22 | 1 Vial, Single-Dose | Hospira, Inc.
61703-0319-22Hospira, Inc.Historical shortage context

Common brands and presentations in this family

These package-level links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.